| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |